DOSSIER · UPDATED 18 NOV 2025

Coherus BioSciences

Coherus BioSciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010,…

coherus.com ↗

This profile is unclaimed — do you work here? Claim it

Founded: 2010
Headcount: 281
Open roles: 13
Last raised: Post Ipo Equity · $50M

Coherus BioSciences website

LEADERSHIP

Founders & key people

Sign up to see founders

OPEN ROLES

Hiring at Coherus BioSciences

View all 13 open roles →

FUNDING

Capital raised

Total Amount Raised: $1,271,227,776

Coherus BioSciences Funding Rounds

Post Ipo Equity
$50,100,000
Feb 12, 2026
Post Ipo Equity
$50,000,000
May 15, 2023
Post Ipo Equity
$50,000,000
May 14, 2023
Post Ipo Debt
$100,000,000
Jan 7, 2022
Post Ipo Debt
$100,000,000
Jan 6, 2022
Post Ipo Debt Investors
Pharmakon Advisors
Post Ipo Debt
$400,000,000
Jan 1, 2022
Post Ipo Debt
$400,000,000
Dec 31, 2021
Post Ipo Debt Investors
Armentum Partners
Post Ipo Equity
$1,960,000
Nov 4, 2021
Post Ipo Equity
$1,960,000
Nov 3, 2021
Post Ipo Equity Investors
Northern Star Partners
Post Ipo Equity
$50,000,000
Feb 2, 2021
Post Ipo Equity
$50,000,000
Feb 1, 2021
Post Ipo Equity Investors
Shanghai Junshi Biosciences Co
Post Ipo Debt
$75,000,000
Jan 8, 2019
Post Ipo Debt
$75,000,000
Jan 7, 2019
Post Ipo Debt Investors
Healthcare Royalty
Post Ipo Equity
$6,806,432
Dec 12, 2017
Post Ipo Equity
$6,806,432
Dec 11, 2017
Post Ipo Equity
$117,100,000
Feb 8, 2017
Post Ipo Equity
$117,100,000
Feb 7, 2017
Post Ipo Equity
$100,000,000
Oct 28, 2016
Post Ipo Equity
$100,000,000
Oct 27, 2016
Post Ipo Equity
$100,000,000
Feb 29, 2016
Post Ipo Equity
$100,000,000
Feb 28, 2016
Post Ipo Equity
$120,000,000
Mar 30, 2015
Post Ipo Equity
$120,000,000
Mar 29, 2015
Series C
$54,700,000
May 19, 2014
Series C
$54,700,000
May 18, 2014
Series C Investors
KKR
Venrock
RA Capital Management
Rock Springs Capital
Lilly Ventures
Sofinnova Ventures
Vivo Capital
Viva Capital Advisors
F-Prime Capital
Helix Ventures
KMG Capital Partners
Eight Roads
IPO
Unknown
Jan 1, 2014
Debt Financing
$28,000,700
Jul 25, 2013
Debt Financing
$28,000,700
Jul 24, 2013
Debt Financing Investors
Helix Ventures
Series B
$61,500,000
Jan 1, 2012
Series B
$61,500,000
Dec 31, 2011
Series B Investors
Daiichi Sankyo
Cook Pharmica
Medpace
Lilly Ventures
Helix Ventures
Debt Financing
$3,794,959
Jul 25, 2011
Debt Financing
$3,794,959
Jul 24, 2011
Series Unknown
$865,666
Mar 10, 2011
Series Unknown
$865,666
Mar 9, 2011
Series A
$1,500,000
Mar 1, 2011
Series A
$1,500,000
Feb 28, 2011
Series A Investors
Helix Ventures
Medpace

Funding info provided by Diffbot.

Sign up to see capital raised

TAGS

Categorized in

Company Collections

These are collections Coherus BioSciences is a part of. Click on the collection name to view similar companies.

Coherus BioSciences' Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

Coherus BioSciences' Tech Stack

LOCATIONS

Where they work

Coherus BioSciences Headquarters Location

333 Twin Dolphin Dr suite 600, Redwood City, CA, 94065-1442

Loading map…